Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie has recently completed a Phase 3b clinical ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

On May 12, Trump signed an executive order stating that U.S. consumers are being overcharged for prescription drugs and that ...

In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing ...

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...

Resmed has announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15. The company also announced that board member Rich Sulpizio is thanked for two decades of ...

ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1570 in its research report dated August 19, 2025.

Sales of rhCollagen and bioinks primed for augmentation following new U.S.-based commercial executive hire -- Raised $3.6 million in registered direct offering in second quarter - REHOVOT ...

UChicago Medicine is launching a national cancer network to bring its academic medicine expertise to other communities in the ...